Latest Breaking News On - Charles dela cruz - Page 3 : comparemela.com

Post-baccalaureate Program Focuses on Lung Disease Research

Post-baccalaureate Program Focuses on Lung Disease Research

Study probes vaccines' effects on people with 'Long COVID'

May 10, 2021 Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this (© stock.adobe.com) A team of Yale School of Medicine researchers is launching a study to determine the effect of vaccination on people with persistent symptoms months after SARS-CoV-2 infection, which has been termed “Long COVID.” The study is led by Yale faculty members Akiko Iwasaki, Aaron Ring, Wade Schulz, Charles Dela Cruz, Erica Spatz, and Harlan Krumholz. The idea for the study came from Survivor Corps, a grassroots COVID patient group. In a poll they posted to their patient community about the effects of vaccination on Long COVID, they found that about 40% of people reported mild to full resolution of their symptoms after they were vaccinated.

Study to determine how COVID-19 vaccine affects people with 'Long COVID'

Study to determine how vaccines affect people with 'Long COVID'

May 10, 2021 Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this (© stock.adobe.com) A team of Yale School of Medicine researchers is launching a study to determine the effect of vaccination on people with persistent symptoms months after SARS-CoV-2 infection, which has been termed “Long COVID.” The study is led by Yale faculty members Akiko Iwasaki, Aaron Ring, Wade Schulz, Charles Dela Cruz, Erica Spatz, and Harlan Krumholz. The idea for the study came from Survivor Corps, a grassroots COVID patient group. In a poll they posted to their patient community about the effects of vaccination on Long COVID, they found that about 40% of people reported mild to full resolution of their symptoms after they were vaccinated.

New Clinical Practice Guideline on Community Acquired Pneumonia;

New Clinical Practice Guideline on Community Acquired Pneumonia; Addresses Testing for Non-Influenza Viral Pathogens Newswise May 04, 2021 – In its latest clinical practice guideline on community-acquired pneumonia the American Thoracic Society’s guidelines panel addresses the use of nucleic acid-based testing for non-influenza viral pathogens. The guideline was published online in the May 1 issue of the American Journal of Respiratory and Critical Care Medicine. An explainer video may be viewed Community-acquired pneumonia is caused by a wide range of respiratory pathogens, prominently including viruses. However, the only viral pathogen addressed by the 2019 clinical practice guideline  was influenza. The panel determined that, given the increasing recognition of non-influenza viral causes of CAP and the expanded availability of diagnostic tests among clinicians, it was necessary to update the previous guideline to help guide treatment.